Vetter, a global leader in prefilled drug-delivery systems and an expert in complex packaging projects, announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions.
The need for expansion is also a result of Vetter’s continuous growth in new filling lines and new lyophilizers, which is driving the need for increased downstream secondary packaging capacity. The project, already underway, is occurring within the second floor of Vetter’s existing Secondary Packaging (VSP) facility and will result in an increase of approximately 32,000 square feet of new packaging capacity.
The planned undertaking, which is expected to be completed over the next several years, will include new fully-automated packaging lines, space for manual and semi-automated packaging processes and assembly equipment for a wide variety of formats. The Vetter serialization and aggregation service, which fulfills current requirements and is prepared for future requirements of regulatory authorities, will also be expanded. A highly flexible, state-of-the-art syringe blister line will include safety device assembly and equipment for packaging Japan quality. The addition of new state-of-the-art assembly machines for pens and autoinjectors will allow Vetter to meet a majority of the growing market need for these systems. Because Vetter suppliers for the platform technologies are market leaders with a strong reputation in the market, a large selection of diverse pen and autoinjector types are offered.
“Often we hear from customers that a high level of expertise in the assembly and packaging of pens, autoinjectors and safety devices is critical for their success,” said Bernd Stauss, Senior Vice President Production/Engineering for Vetter. “Vetter has this experience and can offer a one-stop solution, from development to filling to secondary packaging including serialization of products; a service that is greatly appreciated by our customers.” The demand for integrated solutions is steadily growing. In the future, the pharmaceutical service provider will continue to expand its offering for one-stop-shop solutions - especially in complex areas such as the secondary packaging of end-user friendly devices which support patient safety, convenience and compliance. As a result, Vetter has an eye on the entire product life cycle of its customers with the usual high quality standards.
Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions for vials, syringes and cartridges. Vetter’s customers range from small and midsize to the world’s top 20 pharmaceutical and biotech companies. As a leading solution provider, the CDMO recognizes its responsibility in supporting the needs of its customers in developing devices that contribute to increased patient safety, convenience, and enhanced compliance.
Vetter Pharma International GmbH
Corporate Spokesperson / Specialist External Communications